Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access Email this article to a friend

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Thomas Dörner*, Joerg Kaufmann, William A Wegener, Nick Teoh, David M Goldenberg and Gerd R Burmester

Arthritis Research & Therapy 2006, 8:R74 doi:10.1186/ar1942

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.